Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results

R G Pebody, F Warburton, J Ellis, N Andrews, C Thompson, B von Wissmann, H K Green, S Cottrell, J Johnston, S de Lusignan, C Moore, R Gunson, C Robertson, J McMenamin, M Zambon

Research output: Contribution to journalArticlepeer-review

81 Citations (Scopus)
3 Downloads (Pure)


In 2014/15 the United Kingdom experienced circulation of influenza A(H3N2) with impact in the elderly. Midseason vaccine effectiveness (VE) shows an adjusted VE of 3.4% (95% CI: −44.8 to 35.5) against primary care consultation with laboratory-confirmed influenza and −2.3% (95% CI: −56.2 to 33.0) for A(H3N2). The low VE reflects mismatch between circulating viruses and the 2014/15 northern hemisphere A(H3N2) vaccine strain. Early use of antivirals for prophylaxis and treatment of vulnerable populations remains important.

Original languageEnglish
Number of pages7
Issue number5
Publication statusPublished - 5 Feb 2015


  • influenza vaccine effectiveness
  • United Kingdom
  • vulnerable populations

Cite this